Literature DB >> 2209744

Serological study of the prevalence of toxoplasmosis in asymptomatic patients infected with human immunodeficiency virus.

R E Holliman1.   

Abstract

Asymptomatic individuals seropositive for antibody to human immunodeficiency virus (HIV) were investigated for the presence of toxoplasma specific antibody. Serological examination was performed using multiple assays. Of 500 patients studied 133 had serological evidence of previous exposure to Toxoplasma gondii. Specific IgM was detected in 7 patients using ISAGA and 2 patients by DS-ELISA. The immunoglobulin-G annual seroconversion rate was calculated to be 0.75%. The results of this study indicate 27% of HIV positive patients in the UK are at risk of developing life-threatening secondary reactivation of cerebral toxoplasmosis in association with AIDS. A further 0.5-1% per year may suffer primary toxoplasmosis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2209744      PMCID: PMC2271896          DOI: 10.1017/s0950268800047993

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  8 in total

1.  Direct agglutination test and other assays for measuring antibodies to Toxoplasma gondii.

Authors:  J Johnson; K Duffy; L New; R E Holliman; B S Chessum; D G Fleck
Journal:  J Clin Pathol       Date:  1989-05       Impact factor: 3.411

Review 2.  AIDS commentary. Toxoplasmic encephalitis.

Authors:  B J Luft; J S Remington
Journal:  J Infect Dis       Date:  1988-01       Impact factor: 5.226

3.  Pneumocystis pneumonia and disseminated toxoplasmosis in a male homosexual.

Authors:  W R Gransden; P M Brown
Journal:  Br Med J (Clin Res Ed)       Date:  1983-05-21

4.  Assessment of immunoglobulin-M immunosorbent agglutination assay (ISAGA) for detecting toxoplasma specific IgM.

Authors:  K T Duffy; P J Wharton; J D Johnson; L New; R E Holliman
Journal:  J Clin Pathol       Date:  1989-12       Impact factor: 3.411

5.  Discrepant toxoplasma latex agglutination test results.

Authors:  R E Holliman; J Johnson; K Duffy; L New
Journal:  J Clin Pathol       Date:  1989-02       Impact factor: 3.411

Review 6.  Toxoplasmosis and the acquired immune deficiency syndrome.

Authors:  R E Holliman
Journal:  J Infect       Date:  1988-03       Impact factor: 6.072

7.  Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: clinical and neuropathological findings in 27 patients.

Authors:  B A Navia; C K Petito; J W Gold; E S Cho; B D Jordan; R W Price
Journal:  Ann Neurol       Date:  1986-03       Impact factor: 10.422

Review 8.  Toxoplasmosis in AIDS patients.

Authors:  C U Tuazon
Journal:  J Antimicrob Chemother       Date:  1989-01       Impact factor: 5.790

  8 in total
  5 in total

1.  Seroprevalence of Toxoplasma IgG Antibodies in HIV Positive Patients in and Around Khammam, Telangana State.

Authors:  Basavaraju Anuradha; Chilupuri Preethi
Journal:  J Clin Diagn Res       Date:  2014-09-20

2.  Seroprevalence of cytomegalovirus, Toxoplasma gondii, syphilis, and hepatitis B and C virus infections in a regional population seropositive for HIV infection.

Authors:  D G Johns; M J Gill
Journal:  Can J Infect Dis       Date:  1998-07

3.  Longitudinal study of Toxoplasma seroprevalence in South Yorkshire.

Authors:  J Walker; D J Nokes; R Jennings
Journal:  Epidemiol Infect       Date:  1992-02       Impact factor: 2.451

4.  Seroprevalence of Toxoplasma gondii in newly diagnosed HIV seropositive patients.

Authors:  Anuja Dutta; Preeti R Mehta; Nayana Ingole
Journal:  Indian J Med Res       Date:  2020-11       Impact factor: 2.375

5.  High Seroprevalence of Toxoplasma gondii Antibody in HIV/AIDS Individuals from North of Iran.

Authors:  Mohammad Taghi Rahimi; Seif Ali Mahdavi; Behzad Javadian; Rozita Rezaei; Mahmood Moosazadeh; Mehri Khademlou; Seyed Hosein Seyedpour; Abolghasem Syadatpanah
Journal:  Iran J Parasitol       Date:  2015 Oct-Dec       Impact factor: 1.012

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.